Concepedia

Lingwen Cui

LC

Statistics

Publications

3

Citations

54

H-Index

3

Active since

2022

Affiliations

Beijing University of Chinese Medicine(Current)

Guangzhou University of Chinese Medicine

Lingwen Cui is an author at Beijing University of Chinese Medicine specializing in vascular biology, immunology, and cardiovascular pharmacology.

ORCID

Top concepts

Publications per year

2022–2023

3

Publications

3

Shexiang Tongxin Dropping Pill alleviates M1 macrophage polarization-induced inflammation and endothelial dysfunction to reduce coronary microvascular dysfunction via the Dectin-1/Syk/IRF5 pathway

Lingwen Cui, Yizhou Liu, Yueyao Hu et al. · Journal of Ethnopharmacology · 2023 · 25 citations

, , +9

P2X7R-NEK7-NLRP3 Inflammasome Activation: A Novel Therapeutic Pathway of Qishen Granule in the Treatment of Acute Myocardial Ischemia

Yanqin Li, Xiaoqian Sun, Xiangning Liu et al. · Journal of Inflammation Research · 2022 · 16 citations · Full text

Qishen Granule (QSG) Inhibits Monocytes Released From the Spleen and Protect Myocardial Function via the TLR4-MyD88-NF-κB p65 Pathway in Heart Failure Mice

Yanqin Li, Xuan Li, Xu Chen et al. · Frontiers in Pharmacology · 2022 · 13 citations · Full text

1–3 of 3